WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (Nasdaq: ALTH) today reported results for the first quarter of 2008. For the three months ended March 31, 2008, the Company reported a net loss of $12.0 million, or $(0.18) per share. This compares to a net loss of $8.4 million, or $(0.14) per share, for the first quarter of 2007. For the three months ended March 31, 2008, net cash used in operating activities was $9.3 million. Cash, cash equivalents and investments in marketable securities as of March 31, 2008 totaled $50.5 million.
